Create Invoice

sanofi- aventis Pharma Slovakia - Company Information, finance statistics

Date of updating data: 01.02.2016
Basic information
Business name sanofi- aventis Pharma Slovakia
PIN 35686049
TIN 2020308653
VAT number SK7020000240
Date create 15 March 1996
Company category Spoločnosť s ručením obmedzeným
Registered seat sanofi- aventis Pharma Slovakia
Einsteinova 24
85101
Bratislava
Financial information
Sales and income 9 445 787 €
Profit 419 202 €
Capital 4 137 799 €
Own capital 2 101 565 €
Contact Information
Email eleonora.petroova@sanofi.com
Phone(s) 0233100100, 0233100210
Fax(es) 0233100199
Date of updating data: 01.02.2016
ASSETS 2014
TOTAL ASSETS line. 02 + r. 33 + r. 74 4,946,451
A. Non-current assets r. 03 + r. 11 + r. 21 144,425
A.I. Non-current intangible assets total (r. 04 to r. 10) 12,141
2. Software (013) - /073, 091A/ 12,141
A.II. Non-current tangible assets total (r. 12 to r. 20) 132,284
2. Buildings (021) - /081, 092A/ 50,771
3. Separate movable assets and sets of movable assets (022) - /082, 092A/ 81,513
B. Current assets r. 34 + r. 41 + r. 53 + r. 66 + r. 71 4,700,971
B.I. Total inventory (r. 35 to r. 40) 0
B.I.1. Material (112, 119, 11X) - /191, 19X/ 0
B.II. Long-term receivables sum (r. 42 + r. 46 to r. 52) 178,644
8. Deferred tax asset (481A) 178,644
B.III. Short-term receivables sum (r. 54 + r. 58 to r. 65) 4,422,806
B.III.1. Trade receivables the sum of (r. 55 to r. 57) 3,153,996
1.a. Trade receivables owed by affiliated entities (311A, 312A, 313A, 314A, 315A, 31XA) - /391A/ 3,119,638
1.c. Other trade receivables (311A, 312A, 313A, 314A, 315A, 31XA) - /391A/ 34,358
4. Other claims within the proportionate participation of the addition of receivables to affiliated entities (351A) - /391A/ 1,256,810
9. Other receivables (335A, 33XA, 371A, 374A, 375A, 378A) - /391A/ 12,000
B.V. Financial accounts r. 72 + r. 73 99,521
2. Bank accounts (221A, 22X +/- 261) 99,521
C. Total accruals (r. 75 to r. 78) 101,055
2. Prepaid expenses short-term (381A, 382A) 101,055
LIABILITIES 2014
TOTAL EQUITY AND LIABILITIES r. 80 + r. 101 + r. 141 4,946,451
A. Equity r. 81 + r. 85 + r. 86 + r. 87 + r. 90 + r. 93 + r. 97 + r. 100 2,520,767
A.I. Capital sum (r. 82 to r. 84) 615,183
A.I.1. Share capital (411 or +/- 491) 615,183
A.IV. The legal reserve funds r. 88 + r. 89 61,518
A.IV.1. Legal reserve fund indivisible fund (417A, 418, 421A, 422) 61,518
A.VII. Profit / loss from previous years r. 98 + r. 99 1,424,864
A.VII.1. Retained earnings from previous years (428) 1,424,864
A.VIII. Profit / loss for the accounting period after tax /+-/ r. 01 - r. 81 + r. 85 + r. 86 + r. 87 + r. 90 + r. 93 + r. 97 + r. 101 + r. 141) 419,202
B. Liabilities line. 102 + r. 118 + r. 121 + r. 122 + r. 136 + r. 139 + r. 140 2,425,684
B.II. Long-term provisions r. 119 + r. 120 118,173
2. Other provisions (459A, 45X) 118,173
B.IV. Short-term liabilities total (r. 123 + r. 127 to r. 135) 1,616,221
B.IV.1. Trade payables total (r. 124 to r. 126) 1,087,228
1.a. Trade payables to affiliated entities (321A, 322A, 324A, 325A, 326A, 32XA, 475A, 476A, 478A, 47XA) 711,813
1.c. Other payables (321A, 322A, 324A, 325A, 326A, 32XA, 475A, 476A, 478A, 47XA) 375,415
6. Liabilities to employees (331, 333, 33X, 479A) 228,094
7. Liabilities from social insurance (336) 105,079
8. Tax liabilities and subsidies (341, 342, 343, 345, 346, 347, 34X) 195,820
B.V. Short-term provisions r. 137 + r. 138 691,290
B.V.1. Statutory reserves (323A, 451A) 50,138
2. Other reserves (323A, 32X, 459A, 45XA) 641,152
Date of updating data: 01.02.2016
Income and expenses 2014
** Income from the economic activity of the total sum (r. 03 to r. 09) 9,445,787
III. Revenues from sale of services (602, 606) 9,433,955
VI. Revenues from sales of intangible fixed assets, tangible fixed assets and materials (641, 642) 3,107
VII. Other revenues from economic activity (644, 645, 646, 648, 655, 657) 8,725
** The cost of economic activity along r. 11 + r. 12 + r. 13 + r.14 + r. 15 + r. 20 + r. 21 + r. 24 + r. 25 + r. 26 8,793,552
B. Consumption of material, energy and other non-inventory items supplies (501, 502, 503) 570,637
C Impairment losses on inventories (+/-) (505) 68
D. Services (účtová group of 51) 4,243,886
E. Personnel expenses (r. 16 to r. 19) 3,833,420
E.1. Wages and salaries (521, 522) 2,850,222
3. The cost of social insurance (524, 525, 526) 947,761
4. Social expenses (527, 528) 35,437
F. Taxes and fees (účtová group of 53) 4,350
G. Depreciation and impairment losses on non-current intangible assets and tangible fixed assets (r. 22 + r. 23) 94,933
G.1. Depreciation of intangible assets and property, plant and equipment (551) 94,933
J. Other costs of economic activity (543, 544, 545, 546, 548, 549, 555, 557) 46,258
*** Profit / loss from operating activities (+/-) (r. 02 - r. 10) 652,235
* Added value (r. 03 + r. 04 + r. 05 + r. 06 + r. 07) - (r. 11 + r. 12 + r. 13 + r. 14) 4,619,364
** Revenues from financial activities total r. 30 + r. 31 + r. 35 + r. 39 + r. 42 + r. 43 + r. 44 2,575
XI. Interest income (r. 40 + r. 41) 2,259
XI.1. Interest income from linked entities (662A) 2,157
2. Other interest income (662A) 102
XII. Foreign exchange gains (663) 316
**. The cost of financial activity along r. 46 + r. 47 + r. 48 + r. 49 + r. 52 + r. 53 + r. 54 14,033
O. Exchange rate losses (563) 5,797
Q. Other expenses on financial activities (568, 569) 8,236
*** Profit / loss from financial activities (+/-) (r. 29 - r. 45) -11,458
**** Profit / loss for the accounting period before tax (+/-) (r. 27 + r. 55) 640,777
R. Income tax (r. 58 + r. 59) 221,575
R.1. Income tax expense current (591, 595) 261,352
2. Deferred income taxes (+/-) (592) -39,777
**** Profit / loss for the accounting period after taxation (+/-) (r. 56 - r. 57 - r. 60) 419,202
Date of updating data: 01.02.2016
Date of updating data: 01.02.2016
  • PIN :35686049 TIN: 2020308653 VAT number: SK7020000240
  • Registered seat: sanofi- aventis Pharma Slovakia, Einsteinova 24, 85101, Bratislava
  • Date create: 15 March 1996
  • Directors:
    Person Function Registered seat Date
    RNDr. Soňa Porubská, PhD. Kráľovské údolie 15 Bratislava - mestská časť Staré Mesto 811 06 31.12.2015
    Colette Mutschler avenue de la Garde de Gargan 21 Livry-Gargan 931 90 Francúzska republika 31.12.2015
  • Owners:
    Person Function Share Registered seat
    SANOFI- AVENTIS PARTICIPATIONS 615 183 € (100%) Paríž 750 08 Francúzska republika
    • History of changes in the company and the presentation of trade registers:
      29.01.2016Nový štatutárny orgán:
      konatelia
      RNDr. Soňa Porubská , PhD. Kráľovské údolie 15 Bratislava - mestská časť Staré Mesto 811 06 Vznik funkcie: 31.12.2015
      Colette Mutschler avenue de la Garde de Gargan 21 Livry-Gargan 931 90 Francúzska republika Vznik funkcie: 31.12.2015
      25.04.2014Nové predmety činnosti:
      Vedenie účtovníctva
      01.01.2010Nové sidlo:
      Einsteinova 24 Bratislava 851 01
      27.01.2009Noví spoločníci:
      SANOFI- AVENTIS PARTICIPATIONS rue La Boétie 54 Paríž 750 08 Francúzska republika
      28.12.2005Nové obchodné meno:
      sanofi- aventis Pharma Slovakia s.r.o.
      23.10.2003Nové predmety činnosti:
      sprostredkovateľská činnosť v rozsahu voľnej živnosti
      09.05.2001Nové predmety činnosti:
      reklamná a propagačná činnosť
      15.03.1996Nová právna forma:
      Spoločnosť s ručením obmedzeným
      Nové predmety činnosti:
      prieskum trhu
      konzultačná činnosť ohľadom farmácie